Sanofi Buys Rights to Diabetes Drug From Metabolex - BusinessWeek

[INCIID News Feed]

Proactive Investors USA & Canada
<img alt="" height="1" width="1" />
Sanofi Buys Rights to Diabetes Drug From Metabolex
BusinessWeek
June 25 (Bloomberg) -- Sanofi-Aventis SA agreed to pay closely held Metabolex, Inc. as much as $375 million for rights to an experimental diabetes treatment. The accord gives Sanofi an exclusive license to develop, manufacture and ...
Sanofi-aventis and Metabolex enter licensing deal over diabetes drugProactive Investors USA & Canada
Sanofi, Metabolex in diabetes treatment dealReuters
Sanofi-Aventis signs license deal with MetabolexMarketWatch
Pharma Times -The FINANCIAL -Zenopa
all 27 news articles &raquo;


More...